Baumann, D., Hägele, T., Mochayedi, J., Drebant, J., Vent, C., Blobner, S., . . . Offringa, R. (2020). Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy. Nat Commun.
Citação norma ChicagoBaumann, Daniel, et al. "Proimmunogenic Impact of MEK Inhibition Synergizes With Agonist Anti-CD40 Immunostimulatory Antibodies in Tumor Therapy." Nat Commun 2020.
MLA citiranjeBaumann, Daniel, et al. "Proimmunogenic Impact of MEK Inhibition Synergizes With Agonist Anti-CD40 Immunostimulatory Antibodies in Tumor Therapy." Nat Commun 2020.
Opozorilo: Ti citati niso vedno 100% točni.